Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUP Ocuphire Pharma, Inc.

盘后交易 07-17 18:19:40 EDT

2.05

+0.11

+5.67%

盘后2.00

-0.05-2.44%

17:55 EDT

最高2.08	最低1.98	成交量18.04万
今开1.98	昨收1.94	日振幅5.15%
总市值5,314万	流通市值4,970万	总股本2,592万
成交额36.72万	换手率0.74%	流通股本2,425万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUP","market":"US","secType":"STK","nameCN":"Ocuphire Pharma, Inc.","latestPrice":2.05,"timestamp":1721246400000,"preClose":1.94,"halted":0,"volume":180389,"hourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.05,"latestTime":"17:55 EDT","volume":227,"amount":458.549988,"timestamp":1721253344059},"delay":0,"floatShares":24245078,"shares":25924158,"eps":-0.5026,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.11,"latestTime":"07-17 18:19:40 EDT","open":1.98,"high":2.08,"low":1.98,"amount":367196.90805930004,"amplitude":0.051546,"askPrice":2.13,"askSize":108,"bidPrice":1.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.5026,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"listingDate":1100235600000,"adjPreClose":1.94,"preHourTrading":{"tag":"盘前","latestPrice":2.1,"preClose":1.94,"latestTime":"09:19 EDT","volume":1423,"amount":2970.0998299999997,"timestamp":1721222387078},"postHourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.05,"latestTime":"17:55 EDT","volume":227,"amount":458.549988,"timestamp":1721253344059},"volumeRatio":0.751236,"impliedVol":0.6604,"impliedVolPercentile":0.0119},"requestUrl":"/m/hq/s/OCUP/tweets","defaultTab":"tweets","newsList":[{"id":"2452521361","title":"Ocuphire Pharma, Inc.盘中异动 急速拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452521361","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452521361?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:38","pubTimestamp":1721223507,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价大幅上涨5.99%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为782.76%、589.18%、144.04%，振幅较大的相关个股有Aptevo Therapeutics Inc.、4D Molecular Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.，振幅分别为28.36%、21.71%、19.03%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213827af92c9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213827af92c9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2452944607","title":"Ocuphire Pharma, Inc.盘中异动 下午盘股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452944607","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452944607?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:28","pubTimestamp":1721158119,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时28分，Ocuphire Pharma, Inc.股票出现波动，股价快速跳水5.83%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717032839941f7862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717032839941f7862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2451676623","title":"Ocuphire Pharma, Inc.盘中异动 早盘股价大涨5.30%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451676623","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451676623?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:38","pubTimestamp":1721050686,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价急速上涨5.30%。截至发稿，该股报2.07美元/股，成交量3.8825万股，换手率0.15%，振幅4.07%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213806aef9c04f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213806aef9c04f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2450369523","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450369523","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450369523?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:28","pubTimestamp":1720708129,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时28分，Ocuphire Pharma, Inc.股票出现波动，股价快速上涨5.45%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为558.12%、462.14%、287.64%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.00%、87.19%、82.31%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711222850941f64d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711222850941f64d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2450960819","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450960819","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450960819?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:24","pubTimestamp":1720621469,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时24分，Ocuphire Pharma, Inc.股票出现异动，股价急速拉升5.16%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为2771.27%、1090.08%、712.63%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为119.83%、104.17%、83.64%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710222429af919eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710222429af919eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2449299136","title":"Ocuphire Pharma, Inc.盘中异动 急速下挫5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449299136","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449299136?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:07","pubTimestamp":1720192030,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时07分，Ocuphire Pharma, Inc.股票出现异动，股价急速下跌5.06%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Annovis Bio, Inc.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为11285.95%、2052.41%、88.96%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、61.48%、46.66%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705230710aef82fd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705230710aef82fd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2448391170","title":"Ocuphire Pharma, Inc.盘中异动 早盘快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448391170","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448391170?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:45","pubTimestamp":1719845137,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时45分，Ocuphire Pharma, Inc.股票出现异动，股价快速上涨5.23%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701224538941f2c40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701224538941f2c40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2444212194","title":"Ocuphire Pharma, Inc.盘中异动 大幅上涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444212194","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444212194?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:36","pubTimestamp":1718890560,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时36分，Ocuphire Pharma, Inc.股票出现异动，股价大幅拉升5.23%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为357.20%、153.39%、125.40%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dyadic International, Inc.、Cue Biopharma, Inc.，振幅分别为65244.36%、106.15%、105.93%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213600af8e741c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213600af8e741c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2444431742","title":"Ocuphire Pharma, Inc.盘中异动 早盘大幅下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444431742","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444431742?lang=zh_cn&edition=full","pubTime":"2024-06-18 22:31","pubTimestamp":1718721074,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日22时31分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.36%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Nls Pharmaceutics Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为503.50%、502.87%、322.52%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为91.98%、52.69%、49.60%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618223114941ef3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618223114941ef3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2441241807","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441241807","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441241807?lang=zh_cn&edition=full","pubTime":"2024-06-07 03:53","pubTimestamp":1717703631,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日03时53分，Ocuphire Pharma, Inc.股票出现波动，股价大幅下跌5.14%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Virax Biolabs Group Limited、Fibrobiologics, Inc.、Viracta Therapeutics, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3321.77%、88.62%、67.60%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、87.85%、70.00%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607035351941ed079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607035351941ed079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2441202934","title":"Ocuphire Pharma, Inc.盘中异动 急速拉升5.45%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441202934","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441202934?lang=zh_cn&edition=full","pubTime":"2024-06-06 02:31","pubTimestamp":1717612299,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日02时31分，Ocuphire Pharma, Inc.股票出现异动，股价急速上涨5.45%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Kineta, Inc.、Vigil Neuroscience, Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为152.02%、67.43%、52.45%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为69.07%、63.28%、54.10%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606023139941ec9fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606023139941ec9fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2438509304","title":"Ocuphire Pharma, Inc.盘中异动 临近午盘股价大跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438509304","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438509304?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:44","pubTimestamp":1716911097,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日23时44分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.11%。截至发稿，该股报1.67美元/股，成交量6.953万股，换手率0.27%，振幅6.25%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052823445796810470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052823445796810470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2437945032","title":"Ocuphire Pharma, Inc.盘中异动 早盘股价大涨5.20%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437945032","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437945032?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:45","pubTimestamp":1716389129,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时45分，Ocuphire Pharma, Inc.股票出现异动，股价快速拉升5.20%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。Ocuphire的产品线包括两种小分子产品候选药，针对眼部前段和后段疾病指标。消息层面，截至22时45分，《Ocuphire PharmaMagrath George增持5,000股普通股股份，价值约8,772.5美元》资讯为影响Ocuphire Pharma, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522224529861ee5e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522224529861ee5e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2435258373","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨5.23%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435258373","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435258373?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:38","pubTimestamp":1715607500,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时38分，Ocuphire Pharma, Inc.股票出现异动，股价快速拉升5.23%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。Ocuphire的产品线包括两种小分子产品候选药，针对眼部前段和后段疾病指标。该信息摘要如下：HC Wainwright & Co.：重申Ocuphire Pharma评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213820861ecce6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213820861ecce6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2435325595","title":"HC Wainwright & Co.：重申Ocuphire Pharma(OCUP.US)评级，由买入调整至买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435325595","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435325595?lang=zh_cn&edition=full","pubTime":"2024-05-13 18:55","pubTimestamp":1715597744,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Ocuphire Pharma(OCUP.US)评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131855478761bcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131855478761bcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP"],"gpt_icon":0},{"id":"2434868583","title":"Ocuphire Pharma, Inc.盘中异动 股价大跌5.10%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434868583","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434868583?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:02","pubTimestamp":1715353371,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时02分，Ocuphire Pharma, Inc.股票出现异动，股价急速下跌5.10%。截至发稿，该股报1.86美元/股，成交量4.1612万股，换手率0.16%，振幅6.12%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102302527a594339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102302527a594339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2434850192","title":"Ocuphire Pharma Inc    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434850192","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434850192?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:47","pubTimestamp":1715352420,"startTime":"0","endTime":"0","summary":"   * Ocuphire Pharma Inc    预计将在5月13日公布截至2024年6月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于密歇根州法明顿希尔斯的公司的营收将从去年同期的367万美元增长25.4%，达到460.6万美元。* LSEG 分析师对 Ocuphire Pharma Inc 的平均预期是每股亏损 12 美分。* 华尔街对 Ocuphire Pharma Inc 的 12 个月目标价中位数为 20.00 美元，高于其最新收盘价 1.96 美元。5月10日 - 本摘要于北京时间 5 月 10 日 14:46 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUP"],"gpt_icon":0},{"id":"2434370770","title":"Ocuphire Pharma, Inc.盘中异动 下午盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434370770","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434370770?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:49","pubTimestamp":1715194175,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日02时49分，Ocuphire Pharma, Inc.股票出现异动，股价大幅下跌5.15%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902493687e86802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902493687e86802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0},{"id":"2433180470","title":"Ocuphire Pharma, Inc.盘中异动 股价大涨6.03%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433180470","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433180470?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:39","pubTimestamp":1715006343,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时39分，Ocuphire Pharma, Inc.股票出现异动，股价大幅上涨6.03%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1055.81%、693.65%、62.63%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506223903861eb350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506223903861eb350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUP","BK4007"],"gpt_icon":0},{"id":"2432050909","title":"Ocuphire Pharma, Inc.盘中异动 早盘快速上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432050909","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432050909?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:41","pubTimestamp":1714747267,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日22时41分，Ocuphire Pharma, Inc.股票出现异动，股价快速上涨7.03%。Ocuphire Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Ocuphire Pharma, Inc.公司简介：Ocuphire Pharma Inc 是一家临床阶段的眼科生物制药公司，专注于开发和商业化治疗屈光和视网膜眼部疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032241077925c230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032241077925c230&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocuphire.com","stockEarnings":[{"period":"1week","weight":0.2516},{"period":"1month","weight":0.1758},{"period":"3month","weight":0.1149},{"period":"6month","weight":-0.2996},{"period":"1year","weight":-0.5257},{"period":"ytd","weight":-0.3555}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocuphire Pharma, Inc.是一家临床阶段的眼科生物制药公司，致力于开发和商业化用于治疗多种眼疾的疗法。Ocuphire的产品线目前包括针对眼部适应症的两种小分子候选产品。该公司的主要产品候选产品Nyxol眼药水是一种每日一次无防腐剂的甲磺酸酚妥拉明的眼药水配方，一种非选择性的α-1和α-2肾上腺素能拮抗剂，旨在减少瞳孔大小，目前正在开发有几种适应症，包括昏暗的灯光或夜视障碍，药理性散瞳和老花眼。Ocuphire的第二个候选产品APX3330是每天两次的口服片剂，旨在抑制与视网膜和脉络膜血管疾病（例如糖尿病性视网膜病变和糖尿病性黄斑水肿）相关的血管生成和炎症途径。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.081272},{"month":2,"riseRate":0.5,"avgChangeRate":0.063536},{"month":3,"riseRate":0.35,"avgChangeRate":0.008391},{"month":4,"riseRate":0.421053,"avgChangeRate":0.546155},{"month":5,"riseRate":0.6,"avgChangeRate":4.57464},{"month":6,"riseRate":0.4,"avgChangeRate":-0.017062},{"month":7,"riseRate":0.35,"avgChangeRate":-0.004891},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.005969},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.027171},{"month":10,"riseRate":0.263158,"avgChangeRate":-0.107261},{"month":11,"riseRate":0.315789,"avgChangeRate":-0.064728},{"month":12,"riseRate":0.45,"avgChangeRate":0.058972}],"exchange":"NASDAQ","name":"Ocuphire Pharma, Inc.","nameEN":"Ocuphire Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocuphire Pharma, Inc.,OCUP,Ocuphire Pharma, Inc.股票,Ocuphire Pharma, Inc.股票老虎,Ocuphire Pharma, Inc.股票老虎国际,Ocuphire Pharma, Inc.行情,Ocuphire Pharma, Inc.股票行情,Ocuphire Pharma, Inc.股价,Ocuphire Pharma, Inc.股市,Ocuphire Pharma, Inc.股票价格,Ocuphire Pharma, Inc.股票交易,Ocuphire Pharma, Inc.股票购买,Ocuphire Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocuphire Pharma, Inc.(OCUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocuphire Pharma, Inc.(OCUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}